与衰老相关的星病症严重影响黑色物质
Hidetomo Tanaka1, Seojin Lee1, Ivan Martinez-Valbuena1
1Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada.
Neuropathology and applied neurobiology
|July 22, 2024
概括
我们发现了黑色质星病 (NITAG),这是一个罕见的疾病,在黑体中含有丰富的质阳性天体细胞,通常与帕金森症有关. 这一发现有助于在与衰老相关的星骨病变 (ARTAG) 中对病例进行分层.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 老年学是一门学科.
背景情况:
- 星细胞性病理是病症和与衰老相关的星病 (ARTAG) 的一个关键特征.
- 黑色物质 (SN) 是帕金森症变症中常见的退行部位.
- 尼格拉病理通常是神经元占主导地位,不太强调天体细胞参与.
研究的目的:
- 识别和描述在黑质体中突出天体细胞病理的病例.
- 为了定义一种称为尼格拉尔星形病 (NITAG) 的特定模式.
主要方法:
- 定义NITAG为高密度的ARTAG,在SN中具有最小的神经元tau病理.
- 在三个案例中收集了临床数据并分析了tau病理分布,形态和免疫染.
- 利用双标签免疫光学来确认GFAP和化在星球细胞中的同位.
主要成果:
- 确定了三例男性帕金森症病例:非典型的帕金森症,多系统缩以及创伤性脑病综合征/慢性创伤性脑病.
- 确认了GFAP和酸化在受影响的黑色星球细胞中的同定位.
- 在其他大脑干和大脑灰质区域观察到阳性星球细胞.
结论:
- 建议NITAG作为ARTAG光谱中的罕见神经病理特征,其特征是丰富的阳性星体细胞,主要在SN.
- 强调NITAG不是一个独特的疾病,而是一个有助于分层病例的模式.
- 强调了NITAG概念的实用性,以了解其对各种潜在病理中的神经元功能障碍的贡献.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172